Evidence method
Level · gp.fundamentals.capex_revenue_ratio
12.34% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ABCL · Sep 30, 2022
AbCellera Biologics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001564590-22-037060General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-125.06% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
1740.65% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
37.22% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
26.22% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
11.59% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History18 statesSelf-history eligible
Mar 31, 20220/6 normalizedLevel 3Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20235/6 normalizedLevel 3Sep 30, 20235/6 normalizedLevel 3Dec 31, 20235/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Sep 30, 20246/6 normalizedLevel 3Dec 31, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Sep 30, 20256/6 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 68.21%
- Current
- 12.34%
- Delta
- -55.87%
- Previous
- 594.58%
- Current
- -125.06%
- Delta
- -719.64%
- Previous
- 66.11%
- Current
- 1740.65%
- Delta
- 1674.54%
- Previous
- -18.29%
- Current
- 37.22%
- Delta
- 55.51%
- Previous
- 58.12%
- Current
- 26.22%
- Delta
- -31.90%
- Previous
- 26.38%
- Current
- 11.59%
- Delta
- -14.79%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ABCL Fundamental State →Transitioned To · ABCL CAPEX_INTENSITY_DECREASED →Transitioned To · ABCL CASH_GENERATION_DECREASED →Transitioned To · ABCL GROWTH_INCREASED →Transitioned To · ABCL PROFITABILITY_INCREASED →Transitioned To · ABCL R_AND_D_INTENSITY_DECREASED →Transitioned To · ABCL SBC_INTENSITY_DECREASED →Transitioned To · ABCL Fundamental State →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.